前臨床グレード | 研究グレード | 産業グレード | |
---|---|---|---|
サービスパッケージ | Linearization (Preclinical) | Linearization (Research/Industrial) | |
収量 | >5 mg | >100 µg | |
QC | |||
Endotoxin | 10EU/mg (default) |
10EU/mg (industrial) or no control (Research) |
|
Linearization purification |
AKTA (Circular plasmid) + Anion exchange chromatography (Linearization plasmid) |
Default: Anion exchange chromatography (Circular plasmid) + Isopropanol precipitation (Linearization plasmid) |
|
Linearization QC | HPLC ≥ 95% (need 20 µg needed for HPLC) | AGE (load 200 ng, see single band) | |
Host cell DNA | <5%, qPCR | AGE,<15% plasmid band | |
Total protein | Nano orange <2% (default) | N/A | |
RNA | Non-detectable at 200 ng by AGE | Non-detectable at 200ng by AGE |
追加項目 | 直鎖化(前臨床) | 直鎖化(研究/産業) |
---|---|---|
追加の直鎖化精製 | N/A | Optional--Magnetic bead purification (<100µg) or Anion exchange chromatography(>100 µg) |
Low total protein | NanoOrange <1%, (additional cost) only when quantity>5 mg | NanoOrange <2% only when quantity>5 mg |
Advanced Endotoxin Removal | <0.005EU /µg quantitative TAL (default), LAL (optional) | <0.005EU /µg quantitative TAL (default), LAL (optional) |
Mycoplasma Contamination Assay | Luminescence detection kit | N/A |
Detection of Kanamycin | ELISA | N/A |
Quantitative Linearization by HPLC | Additional cost if >98% | Tentative >95%, Additional cost if >98% |
Animal Free Production Process with TSE/BSE certification | RNase, BsaI/EcoRI/BspQI , TSE/BSE certification | RNase, BsaI/EcoRI/BspQI , TSE/BSE certification |
Bio-burden Assay | 48 hr YPD and LB | 48 hr YPD and LB |
Nicked plasmid treatment | T4 ligase treated circularization | T4 ligase treated circularization |
IVTの成功に必要な
高純度直鎖化プラスミド
高収量・高純度のmRNA作製
とより良いタンパク質発現
ダウンストリームアプリケーションに最適な、厳格なエンドトキシンコントロールと安全管理
厳格な管理でRNA、宿主DNA、残存宿主タンパク質、酵素のコンタミネーションリスクを最低限に
Linearized plasmid purity% | Linear plasmid% | IVT yield (μg) |
---|---|---|
50% | 50% | 16.8 |
90% | 90% | 18.4 |
95% | 95% | 24.7 |
98% | 98% | 23.8 |
>98% | 100% | 24.9 |